PATENT CLAIM ANALYSIS

Application Number: 15779829
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "560000"]

Abstract:
The invention relates to lipid compounds of formula (I) and their pharmaceutically acceptable salts for the prevention and/or treatment of ophthalmic disorders such as retinal degenerative disorders and ocular inflammatory diseases: (I) (wherein R 1  is either a C 9  to C 22  alkyl group, or a C 9  to C 22  alkenyl group having from 1 to 6 double bonds; R 2  is selected from the group consisting of a halogen atom, a hydroxy group, an alkyl group, an alkoxy group, an alkylthio group, a carboxy group, an acyl group, an amino group, and an alkylamino group; R 3  is a hydrogen atom, or a group R 2 ; R 4  is a carboxylic acid or a derivative thereof; and X is methylene (—CH 2 —), or an oxygen or sulfur atom).

Claim (Index 34):
A method of preventing and/or treating an ophthalmic disorder as defined in any one of  claims 1  to  9 , said method comprising the step of administering to a patient in need thereof (e.g. a human subject) a pharmaceutically effective amount of a lipid compound of formula (I), or a pharmaceutically acceptable salt thereof, as defined in any one of  claims 1  and  10  to  29 .

Metadata:
- Claim Count in Document: 69.0
- Percentile: 93.0
- Lexical Diversity: 2.01282
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13054212', '12293966', '12446615', '12741890', '13319101']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7635168659144087
- 35 USC 102 Novelty (BERT): 0.5193652684885463
- Combined Prediction Score: 0.7391017061718225
- Mean Citation Score: 278.36449600000003
- Max Citation Score: 309.60422
- Similarity Product: 205.7578574427021

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test